Chengdu Kanghua Biological Products Co., Ltd.

SZSE:300841.SZ

79.25 (CNY) • At close November 27, 2023
Bedrijfsnaam Chengdu Kanghua Biological Products Co., Ltd.
Symbool 300841.SZ
Munteenheid CNY
Prijs 64.68
Beurswaarde 8,709,162,000
Dividendpercentage 4.05%
52-weken bereik 55.52 - 111.97
Industrie Biotechnology
Sector Healthcare
CEO Mr. Qinghan Wang
Website https://www.kangh.com

An error occurred while fetching data.

Over Chengdu Kanghua Biological Products Co., Ltd.

Chengdu Kanghua Biological Products Co., Ltd. engages in the research, development, production, sale, and technical service of biological products in China. It offers group ACYW135 meningococcal polysaccharide vaccines; and freeze-dried human diploid cell rabies vaccines. The company also develops seasonal influenza vaccines without preservatives, which completed phase III clinical trials;

Vergelijkbare Aandelen

Financiële Gegevens

Cijfers zijn in miljoenen (CNY)

Cijfers zijn in miljoenen (CNY)